Mukund Paravasthu, Chief Operating Officer at NovoCure Ltd (NVCR), sold 250 shares at $18.54 ($5K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Open-market sale of $5k NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2025-05-05 | $11K | — | Filing → |
| NVCR | SELL | 2025-03-03 | $40K | — | Filing → |
| NVCR | SELL | 2025-01-15 | $116K | — | Filing → |